X

ASCPT News

ASCPT News and Upcoming Events


Jul23 FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D

FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D On July 9, 2021, the US Food and Drug Administration (FDA) approved KERENDIA (finerenone) to reduce ...
Read More..

Jul23 FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021

FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021 The US Food and Drug Administration (FDA) in collaboration with Duke-Margolis will host a two-day ...
Read More..

Jul16 FDA News: Issue 22, July 2021

FDA News: Issue 22, July 2021 FDA Approves RYLAZE [Asparaginase Erwinia Chrysanthemi (recombinant)-rywn] for the Treatment of ALL ...
Read More..

Jul01 ASCPT News: July 2021

ASCPT News: July 2021 Stay up to date on the latest in clinical pharmacology and translational science.
Read More..

Jul01 I am ASCPT: Qi Liu

I am ASCPT: Qi Liu Qi Liu, PhD, Senior Science Advisor, US Food and Drug Administration, Silver Spring, Maryland
Read More..

Jul01 I am ASCPT: Daniel Rosenbloom

I am ASCPT: Daniel Rosenbloom Daniel Rosebloom, PhD, Associate Principal Scientist, Merck & Co., Brooklyn, New York
Read More..

Jul01 I am ASCPT: Joseph Jilek

I am ASCPT: Joseph Jilek Joseph Jilek, PhD, Postdoctoral Student, University of Arizona, Tucson, Arizona
Read More..

Jul01 I am ASCPT: João A. Abrantes

I am ASCPT: João A. Abrantes João A. Abrantes, PhD, Senior Scientist, F. Hoffman-La Roche, Basel, Switzerland
Read More..

Jun21 FDA News: FDA Approves TEMBEXA (Brincidofovir) for the Treatment of Human Smallpox Disease in Adult and Pediatric Patients Including Neonates

FDA News: FDA Approves TEMBEXA (Brincidofovir) for the Treatment of Human Smallpox Disease in Adult and Pediatric Patients Including Neonates On June 4, 2021, the US Food and Drug Administration (FDA) approved TEMBEXA (brincidofovir) tablet...
Read More..

Jun21 FDA News: FDA Announces Availability of a Final Guidance Titled COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry

FDA News: FDA Announces Availability of a Final Guidance Titled COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry On February 22, 2021, the US Food and Drug Administration (FDA) announced the availability of a fin...
Read More..
Photo Gallery
Recent News
  • FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D
    July 23, 2021
  • FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021
    July 23, 2021
  • CTS Students and Trainees Step Into the Spotlight
    July 20, 2021
Contact Us